Biogen shares jump 4.7% premarket on hopes for its Alzheimer’s treatment lecanemab
admin Biogen Inc. shares BIIB, -0.43% rose 4.7% in premarket trade Monday, after MorphoSys and partner…
Read MoreBiogen Inc. shares BIIB, -0.43% rose 4.7% in premarket trade Monday, after MorphoSys and partner…
Read More